Targeting GPX4 to Overcome Sorafenib Resistance of Human Hepatocellular Carcinoma by Inducing Ferroptosis.

Tang HH, Hsu CP, Su PY, Tsai SP, Doan LH, Chen CY, Chen HC, Wang PY, Cheng TS, Huang CF, Su CL

Open source

DOI
10.1002/jcp.70078
Published
2025 Aug
Container
Journal of cellular physiology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/jcp.70078,
  title = {Targeting GPX4 to Overcome Sorafenib Resistance of Human Hepatocellular Carcinoma by Inducing Ferroptosis.},
  author = {Tang HH and Hsu CP and Su PY and Tsai SP and Doan LH and Chen CY and Chen HC and Wang PY and Cheng TS and Huang CF and Su CL},
  year = {2025},
  journal = {Journal of cellular physiology},
  doi = {10.1002/jcp.70078},
  url = {https://doi.org/10.1002/jcp.70078}
}

RIS

TY  - JOUR
TI  - Targeting GPX4 to Overcome Sorafenib Resistance of Human Hepatocellular Carcinoma by Inducing Ferroptosis.
AU  - Tang HH
AU  - Hsu CP
AU  - Su PY
AU  - Tsai SP
AU  - Doan LH
AU  - Chen CY
AU  - Chen HC
AU  - Wang PY
AU  - Cheng TS
AU  - Huang CF
AU  - Su CL
PY  - 2025
JO  - Journal of cellular physiology
DO  - 10.1002/jcp.70078
UR  - https://doi.org/10.1002/jcp.70078
ER  - 

APA

HH, T., CP, H., PY, S., SP, T., LH, D., CY, C., HC, C., PY, W., TS, C., CF, H., & CL, S. (2025). Targeting GPX4 to Overcome Sorafenib Resistance of Human Hepatocellular Carcinoma by Inducing Ferroptosis.. Journal of cellular physiology. https://doi.org/10.1002/jcp.70078

Source records